- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02532127
Dentomaxillofacial Paediatric Imaging: An Investigation Towards Low Dose Radiation Induced Risks (DIMITRA)
Cone Beam Computed Tomography (CBCT) is an emerging X-ray technology that has found wide applications in dentomaxillofacial imaging. The ability to provide high-resolution 3D images has resulted in a significant increase in the volume of dental radiology procedures. Although CBCT is associated with higher radiation risk to the patient than conventional dental X-ray imaging (intraoral or panoramic), it is considered to be 'low dose' imaging as defined by the High Level Expert Group (HLEG) with doses ranging from a few microsieverts (μSv) to millisieverts (mSv) per examination.
This proposal is set to tackle important issues raised by the HLEG and the Multidisciplinary European Low Dose Initiative (MELODI) platform. In particular, as deduced by the name DIMITRA (Dentomaxillofacial paediatric imaging: an investigation towards low dose radiation induced risks), the project focuses on the uncertainties associated with radiation-induced health risks at low doses in paediatric dentistry and is a multidisciplinary effort to approach the involved risks from different yet interrelated perspectives: radiobiological characterisation, dosimetric quantification, epidemiological surveying and image quality & dose optimization. A unique Monte Carlo simulation (MC) framework will be used to accurately calculate organ doses in dental CBCT imaging, to quantify the radiation induced risk and to feed the radiobiology team with the appropriate data towards the identification, development and validation of biomarkers for radiation induced health effects. Furthermore, it will constitute the basis upon setting up a gender and age related epidemiology study. The balance between image quality and dose levels will be explored aiming at reducing the risk through image quality optimization.
It is expected that DIMITRA's outcomes and deliverables can be presented to a wider forum via a dissemination meeting, leading to further recommendations and potential future adaptations for the use of CBCT in paediatric dentistry.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Prospective study with saliva sampling: Patients referred for a CBCT scan from their doctor
- Retrospective study: recorded patients (age 0 - 22) referred to UZ Leuven in the last 2 years including cleft palate patients
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Saliva sampling
Cells will be collected from consenting participants just before and after (30 min and 24 hr) exposure to CBCT, by brushing a swab against the inner cheek, which can be done by the patients themselves.
Swab kits are provided together with an envelope for sending the swabs back.
|
Cells will be collected from consenting participants just before and after (30 min and 24 hr) exposure to CBCT, by brushing a swab against the inner cheek, which can be done by the patients themselves.
Swab kits are provided together with an envelope for sending the swabs back.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient-specific dosimetry
Time Frame: dose retrospectively calculated for each patient up to 1 week after irradiation, patients will be followed until the end of the study (May 2017)
|
Using a Monte-Carlo based simulator, specifically designed for dental CBCT imaging, adjusted towards specific CBCT geometries and a series of realistic voxel models of paediatric patients will allow the assessment of variability in doses due to differences in anatomy between patients.
The organ and effective doses are used for calculating the associated age and gender related cancer risks attributable to dental and maxillofacial CBCT scans.
|
dose retrospectively calculated for each patient up to 1 week after irradiation, patients will be followed until the end of the study (May 2017)
|
Saliva sampling
Time Frame: 30 minutes before radiation
|
30 minutes before radiation
|
|
Identify and develop biomarkers for radiation-induced health effects
Time Frame: 24 hours after CBCT radiation
|
24 hours after CBCT radiation
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- S56942
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Radiation Dosage
-
Dr. Panagiota ManavaCompleted
-
University of WashingtonCompletedComputed Tomography | Radiation DosageUnited States
-
University Hospital, BrestCompletedVancomycin DosageFrance
-
Chiang Mai UniversityUnknownIntraocular Pressure | Caffeine DosageThailand
-
Ruhr University of BochumUnknownPropofol Dosage | Electroencephalography | Gender IdentityGermany
-
ARCIM Institute Academic Research in Complementary...University Hospital TuebingenCompletedThermogenesis by Different-dosage Ginger Flour FootbathsGermany
-
ARCIM Institute Academic Research in Complementary...University Hospital TuebingenCompletedThermogenesis by Different-dosage Mustard Flour FootbathsGermany
-
Brooke Army Medical CenterCompletedAdministration and Dosage of Ketamine | Endoscopic SedationUnited States
-
University of California, San FranciscoNational Institute on Drug Abuse (NIDA)CompletedTobacco Smoking | Vaping | Nicotine Administration & Dosage | E-cigarettes | E-LiquidUnited States
-
University Hospital, Clermont-FerrandActive, not recruitingHigh Dosage BuprenorphineFrance
Clinical Trials on Saliva sampling
-
Centre Hospitalier Universitaire de NīmesTechnological Innovations for Detection and Diagnosis LaboratoryCompleted
-
University Hospital, BrestCompletedCongenital Hip DislocationFrance
-
ID SolutionsCompletedRespiratory Tract InfectionsFrance
-
Centre Hospitalier Sud FrancilienNot yet recruitingBacteria in Breast MilkFrance
-
University of ZagrebCroatian Science FoundationUnknownPrecancerous Lesions | Oral Cavity Squamous Cell Carcinoma | Saliva Altered
-
Centre Hospitalier Universitaire de NīmesCompleted
-
Istanbul Medipol University HospitalCompletedPeriodontitis | Diagnose DiseaseTurkey
-
Rush University Medical CenterNational Center for Complementary and Integrative Health (NCCIH)Completed
-
Selcuk UniversityTC Erciyes University; Dokuz Eylul University; Ankara University; Selcuk University...Not yet recruitingSudden Cardiac Death | Arrythmia | ICDTurkey
-
Istanbul Saglik Bilimleri UniversityCompleted